Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin as Adjuvant Treatment for ADHD in Adults

NCT03062839 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.

NCT NCT03062839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin as Adjuvant Treatment for ADHD in Adults
Lead sponsor
Hospital Israelita Albert Einstein
Phase
Phase 3
Overall status
Unknown status
Start date
September 1, 2017
Completion date
June 30, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder